Repositorio Dspace

Listar Enfermedades Desmielinizantes.artículos por autor "Fernández Liguori, Nora"

Listar Enfermedades Desmielinizantes.artículos por autor "Fernández Liguori, Nora"

Ordenar por:Orden:Resultados:

  • Camerlingo, Sebastián; Rubinstein, Fernando; Ysrraelit, María Célica; Correale, Jorge; Carnero Contentti, Edgar; Rojas, Juan Ignacio; Patrucco, Liliana; Del Valle Leguizamon, Felisa; Tkachuk, Verónica A.; Fernández Liguori, Nora; Cristiano, Edgardo; Mainella, Carolina; Zanga, Gisela; Carrá, Adriana; Marrodán, Mariano; Martínez, Alejandra Diana; Silva, Berenice Anabel; Alonso, Ricardo (Sage Publications, 2024-01-21)
    Background and objectives: Primary-progressive multiple sclerosis (PPMS) is characterized by gradual neurological deterioration without relapses. This study aimed to investigate the clinical impact of gender and age at ...
  • Barboza, Andrés G.; Gaitán, María Inés; Alonso, Ricardo; Ysrraelit, María Célica; Luetic, Geraldine G.; Liwacki, Susana; Patrucco, Liliana; Halfon, Mario Javier; Burgos, Marcos; Mainella, Carolina; Piedrabuena, Raúl; Recchia, Luciano; Steinberg, Judith; Tkachuk, Verónica A.; Zanga, Gisela; Carra, Adriana; Chertcoff, Aníbal; Fernández Liguori, Nora; Lázaro, Luciana; Menichini, María Laura (Elsevier, 2022-02-09)
    Background: There has been an increase in the number of reports of multiple sclerosis (MS) rebound activity (RA), which is usually defined as a severe disease reactivation after natalizumab or fingolimod withdrawal that ...
  • Alonso, Ricardo; Garcea, Orlando; Eizaguirre, María Barbara; Man, Federico; Lopez Bizzo, Abril; Cohen, Leila; Rojas, Juan Ignacio; Patrucco, Liliana; Cristiano, Edgardo; Pita, Cecilia; Tkachuk, Verónica A.; Balbuena Aguirre, María Eugenia; Carnero Contentti, Edgar; López, Pablo Adrián; Pettinicchi, Juan Pablo; Deri, Norma; Miguez, Jimena; Pappolla, Agustín; Lázaro, Luciana; Fernández Liguori, Nora; Correale, Jorge; Carrá, Adriana; Silva, Berenice Anabel (Elsevier, 2020-12-02)
    Introduction: Over the past decade, numerous disease modifying drugs (DMDs) for relapsing- remitting multiple sclerosis (RRMS) have been approved in Argentina. The use of oral DMDs (oDMDs) has increased in recent years, ...

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta